{"id":17740,"date":"2014-03-06T10:30:00","date_gmt":"2014-03-06T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/garattini-lindustria-farmaceutica-fa-i-suoi-interessi-lo-stato-deve-difenderci\/"},"modified":"2014-03-06T10:30:00","modified_gmt":"2014-03-06T09:30:00","slug":"garattini-lindustria-farmaceutica-fa-i-suoi-interessi-lo-stato-deve-difenderci","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/garattini-lindustria-farmaceutica-fa-i-suoi-interessi-lo-stato-deve-difenderci\/","title":{"rendered":"Garattini: &quot;The pharmaceutical industry has its own interests, the state must defend us&quot;"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font face=\"Calibri\"><font size=\"3\">by Domenico De Felice | July 3, 2013 | <img decoding=\"async\" class=\"rg_i\" name=\"4L_dj44IQRfzLM:\" alt=\"\" data-src=\"https:\/\/encrypted-tbn1.gstatic.com\/images?q=tbn:ANd9GcQN_4mS448OzZ9rsZNWbLKANnar90mKInS_dFhbugLS-7ALmVesUQ\" data-sz=\"f\" style=\"margin-top: 0px; width: 82px; height: 23px; margin-left: 0px; margin-right: 0px\" src=\"https:\/\/encrypted-tbn1.gstatic.com\/images?q=tbn:ANd9GcQN_4mS448OzZ9rsZNWbLKANnar90mKInS_dFhbugLS-7ALmVesUQ\" \/>&nbsp; Society<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 16.5pt; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span style=\"font-family: &quot;Helvetica&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font size=\"3\">There <b>Supreme Court of the United States of America<\/b> rejected a compensation to the <\/font><a target=\"_blank\" href=\"http:\/\/www.nytimes.com\/2013\/03\/05\/business\/justices-to-take-up-case-on-generic-drug-makers-liability.html?pagewanted=all&amp;_r=0\" rel=\"noopener\"><span style=\"color: windowtext; text-decoration: none; text-underline: none\"><font size=\"3\">small town <b>Karen Barlett<\/b> of New Hampshire<\/font><\/span><\/a><font size=\"3\"> for a serious event, as admitted by the Court itself, caused by taking a painkiller <b>generic<\/b>. The same Supreme Court, in 2009, had instead established that patients who believed they were damaged could bring the manufacturers of <b>brand name drugs<\/b>. As if to say that since i <b>generic drugs<\/b> are marketed on the basis of the corresponding brand-name drugs, which need to be tested, only brand-name drugs can be subject to trial. In short, it doesn&#039;t matter what makes up the generic drug, the blame remains with the branded drug from which it derives! In Use the<b>80% on the market is generics<\/b> and if patients have serious complications it doesn&#039;t matter. In <b>Italy<\/b> the market share of the generic is around<b> 20%<\/b>. All over the world it is necessary to save on the cost of medicines without risking, in my opinion, the health of citizens.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 16.5pt; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span style=\"font-family: &quot;Helvetica&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font size=\"3\">But wouldn&#039;t it be easier to know exactly the composition of generics as an active ingredient and excipients? Couldn&#039;t they be exactly the same and cost less due to poor packaging, if not absent, lack of marketing studies or something else? It couldn&#039;t be <b>save<\/b> on the expenses of very expensive medical congresses in pleasant places that have nothing to do with the health of the citizens? Who plays on the health of patients? <\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 16.5pt; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><span style=\"font-family: &quot;Helvetica&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font size=\"3\">It would be enough for the pharmaceutical industries to produce a <\/font><a target=\"_self\" href=\"http:\/\/www.ilfattoquotidiano.it\/2012\/06\/23\/caro-grillo-se-tutti-i-farmaci-li-chiamassimo-specifici\/272557\/\" rel=\"noopener\"><span style=\"color: windowtext; text-decoration: none; text-underline: none\"><font size=\"3\">single drug,<i>specific<\/i>for each pathology<\/font><\/span><\/a><font size=\"3\"> to a <b>balanced social cost for essential and chronic pathologies<\/b>. The others were at a higher cost to reduce abuse and &quot;<i>buffer stock<\/i>\u201d<\/p>","protected":false},"excerpt":{"rendered":"<p>di Domenico De Felice | 3 luglio 2013 | &nbsp; Societ&agrave; La Corte Suprema degli Stati Uniti d&rsquo;America ha bocciato un risarcimento alla cittadina Karen Barlett del New Hampshire per un evento grave, come ammesso dalla stessa Corte, causato dall&rsquo;assunzione di un antidolorifico generico. La stessa Corte Suprema, nel 2009, aveva invece stabilito che i &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17740","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17740"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}